Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections
- 1 June 1992
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 107 (2-3) , 277-284
- https://doi.org/10.1007/bf02245148
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphineBrain Research, 1989
- Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbensBrain Research, 1987
- Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Chronic treatment with bromocriptine induces behavioral supersensitivity in ratsLife Sciences, 1986
- Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioningLife Sciences, 1986
- The effects of low doses of morphine on the activity of dopamine-containing cells and on behaviorLife Sciences, 1982
- Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Drug-environment interaction: Context dependency of cocaine-induced behavioral sensitizationLife Sciences, 1981
- Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activityPharmacology Biochemistry and Behavior, 1973